Free Float 53,89 %
Shares Float 601,97 M
Shares Outstanding 1,12 B
Shenzhen Kangtai Biological Products Co., Ltd.
Share · CNE100002Q33 (XSHE)
AI-Powered Analysis
Fundamental Analysis
Find out what the numbers really say — before the market does
Analyze now
News Sentiment
Are today's headlines a buy signal or a red flag?
Analyze now
Buy / Hold / Sell
Should you Buy, Hold, or Sell? Get the AI verdict now.
Analyze now
Risk Assessment
Uncover hidden risks before they hit your portfolio.
Analyze now
Fair Value
Is this stock cheap, fairly priced, or overvalued?
Analyze now
Latest AI Analyses of Shenzhen Kangtai Biological Products Co., Ltd.
No Price
Closing Price XSHE 29.04.2026:
14,17 CNY
29.04.2026 07:04
Current Prices from Shenzhen Kangtai Biological Products Co., Ltd.
| Exchange | Ticker | Currency | Last Trade | Price | Daily Change |
|---|---|---|---|---|---|
 SHENZHEN STOCK EXCHANGE |
300601.SZ
|
CNY
|
29.04.2026 07:04
|
14,17 CNY
| 0,010 CNY
+0,07 %
|
Share Float & Liquidity
Invested Funds
The following funds have invested in Shenzhen Kangtai Biological Products Co., Ltd.:
Fund | Vol. in million 0,76 | Percentage (%) 0,02 % |
Fund | Vol. in million 126,25 | Percentage (%) 0,01 % |
Fund | Vol. in million 29,98 | Percentage (%) 0,01 % |
Fund | Vol. in million 32,98 | Percentage (%) 0,01 % |
Fund | Vol. in million 166,94 | Percentage (%) 0,01 % |
Company Profile for Shenzhen Kangtai Biological Products Co., Ltd. Share
Shenzhen Kangtai Biological Products Co., Ltd. researches, develops, produces, and sells various types of human vaccines in China. The company's products include cell-free whitebait b-type haemophilus influenzae combined vaccine, SARS-COV-2 vaccine, recombinant hepatitis B vaccine, 23-valent pneumococcal polysaccharide vaccine, diphtheria tetanus acellular pertussis and haemophilus influenzae type b combined vaccine, haemophilus influenzae type b conjugate vaccine, measles and rubella combined with live attenuated vaccine, 13-valent pneumococcal conjugate vaccine, rabies vaccine, inactivated poliomyelitis vaccine, and HIB conjugate vaccine. It has an agreement between YTB and Yong Tai Berhad in relation to the development and commercialization of Covid-19 inactivated vaccine in Malaysia. Shenzhen Kangtai Biological Products Co., Ltd. was founded in 1992 and is based in Shenzhen, China.
Company Data
Name Shenzhen Kangtai Biological Products Co., Ltd.
Company Shenzhen Kangtai Biological Products Co., Ltd.
Website
https://www.biokangtai.com
Primary Exchange
SHENZHEN STOCK EXCHANGE
SHENZHEN STOCK EXCHANGE
ISIN CNE100002Q33
Asset Class Share
Sector Healthcare
Industry Drug Manufacturers - Specialty & Generic
CEO Xiang Miao
Market Capitalization 16 Mrd.
Country China
Currency CNY
Employees 1,9 T
Address Science and Technology Park, 518057 Shenzhen
IPO Date 2017-02-08
Dividends from 'Shenzhen Kangtai Biological Products Co., Ltd.'
| Ex-Date | Dividend per Share |
|---|---|
| 06.06.2025 | 0,09 CNY |
| 14.06.2024 | 0,20 CNY |
| 13.10.2023 | 0,18 CNY |
| 02.06.2022 | 0,85 CNY |
| 29.09.2021 | 0,30 CNY |
| 17.08.2020 | 0,30 CNY |
| 05.07.2019 | 0,25 CNY |
| 13.06.2018 | 0,08 CNY |
| 07.06.2017 | 0,06 CNY |
Stock Splits
| Date | Split |
|---|---|
| 13.06.2018 | 1497457:1000000 |
Ticker Symbols
| Name | Symbol |
|---|---|
| SHENZHEN STOCK EXCHANGE | 300601.SZ |
More Shares
Investors who hold Shenzhen Kangtai Biological Products Co., Ltd. also have the following shares in their portfolio:
